0001493152-24-028186.txt : 20240717 0001493152-24-028186.hdr.sgml : 20240717 20240717163015 ACCESSION NUMBER: 0001493152-24-028186 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Margrave David R. CENTRAL INDEX KEY: 0001813162 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39318 FILM NUMBER: 241122589 MAIL ADDRESS: STREET 1: 1920 MCKINNEY AVENUE, 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantern Pharma Inc. CENTRAL INDEX KEY: 0001763950 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 463973463 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 972-277-1136 MAIL ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: Lantern Pharma DATE OF NAME CHANGE: 20190108 4 1 ownership.xml X0508 4 2024-07-15 0 0001763950 Lantern Pharma Inc. LTRN 0001813162 Margrave David R. 1920 MCKINNEY AVENUE, 7TH FLOOR DALLAS TX 75201 0 1 0 0 Chief Financial Officer 0 Stock Option (Right to Buy) 4.35 2024-07-15 4 A 0 52000 0.00 A 2034-07-15 Common Stock 52000 52000 D The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024. /s/ David R. Margrave 2024-07-17